![]() In summary, NLE exhibits anti-leukemic properties in patient primary CLL cells and demonstrates clinical efficacy, warranting further investigation as a potential therapy for CLL.Ībstract = "Chronic lymphocytic leukemia (CLL) is the most common adult leukemia and is currently incurable. Biochemical analyses revealed that NLE also inhibits Bcl-2 and p53 proteins. Furthermore, NLE treatment resulted in LC3-I cleavage. NLE also caused loss of mitochondrial outer membrane permeability and nuclear translocation of apoptosis-inducing factor. However, a pan-caspase inhibitor only partially blocked NLE-mediated cell death. ![]() ![]() Annexin-V staining and poly(ADP-ribose) polymerase 1 (PARP-1) and caspase 3 cleavage were observed after NLE treatment. NLE induced a dose-dependent reduction in CLL cell viability with significant apoptosis observed at 0.06% (w/v) by 24 h. NLE-mediated apoptosis was examined in peripheral blood mononuclear cells (PBMCs) from 41 patients with CLL. To expand the therapeutic armamentarium, we investigated neem leaf extract (NLE) after a patient with CLL demonstrated disease regression upon taking oral NLE. Chronic lymphocytic leukemia (CLL) is the most common adult leukemia and is currently incurable.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |